A qualitative interview study exploring the lived experiences of adults, adolescents, and children with chronic inducible cold urticaria
This study is the first to report the ColdU experiences directly from patients. It identifies hives and itch as being the core symptoms and describes the debilitating nature of ColdU and its substantial impact on the HRQoL of all age ranges.
Authors
- Chien‐Chia Chuang (ORCID: https://orcid.org/0000-0002-0895-4998)
- Renata Martincova
- Efstathios Zikos (ORCID: https://orcid.org/0000-0001-7110-6863)
- Marek Król (ORCID: https://orcid.org/0000-0001-6962-6026)
- A. Alladin
- Jingdong Chao
- Isabelle Guillemin
- Ella Brookes (ORCID: https://orcid.org/0009-0001-9710-3799)
Institutions
- BG Group (United Kingdom) (GB)
- Regeneron (United States) (US)
- Sanofi (France) (FR)
- AVEO Oncology (United States) (US)
- Sanofi (Czechia) (CZ)
- IQ Solutions (US)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1186/s41687-025-00970-6
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00